Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in- Capital
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Total
Beginning balance at Jan. 02, 2021 $ 51 $ 260,260 $ (7,146) $ (215) $ (169,461) $ 83,489
Beginning balance (in shares) at Jan. 02, 2021 48,091          
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)         (10,339) (10,339)
Issuance of shares in connection with stock option exercise $ 2 3,659       3,661
Issuance of shares in connection with stock option exercise (in shares) 2,060          
Issuance of shares in connection with restricted stock units vesting $ 3 986       989
Issuance of shares in connection with restricted stock units vesting (in shares) 2,665          
Issuance of stock awards   778       778
Issuance of stock awards (in shares) 143          
Issuance of shares in connection with BOD Fees   23       23
Issuance of shares in connection with BOD Fees (in shares) 1          
Registration costs - common stock   (68)       (68)
Officers and directors stock purchase plan   4       4
Share-based compensation   17,066       17,066
Stock repurchase   (45) (479)     (524)
Actuarial gain (loss) on defined benefit plan       307   307
Unrealized gain (loss) on deferred compensation trust assets       89   89
Effect of changes in foreign currencies       93   93
Ending balance at Jan. 01, 2022 $ 56 282,663 (7,625) 274 (179,800) 95,568
Ending balance (in shares) at Jan. 01, 2022 52,960          
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)         (951) (951)
Issuance of shares in connection with stock option exercise   1,284       $ 1,284
Issuance of shares in connection with stock option exercise (in shares) 738         738,000
Issuance of shares in connection with restricted stock units vesting $ 1 (1)        
Issuance of shares in connection with restricted stock units vesting (in shares) 872          
Issuance of stock awards to consultants   81       $ 81
Issuance of stock awards to consultants (in shares) 10          
Issuance of shares in connection with BOD Fees   22       22
Issuance of shares in connection with BOD Fees (in shares) 3          
Issuance of shares in connection with ESPP   795       $ 795
Issuance of shares in connection with ESPP (in shares) 107         107,000
Officers and directors stock purchase plan   26       $ 26
Officers and directors stock purchase plan (in shares) 3          
Share-based compensation   12,395       12,395
Stock repurchase     0      
Actuarial gain (loss) on defined benefit plan       872   872
Unrealized gain (loss) on deferred compensation trust assets       (147)   (147)
Effect of changes in foreign currencies       127   127
Ending balance at Dec. 31, 2022 $ 57 297,265 (7,625) 1,126 (180,751) 110,072
Ending balance (in shares) at Dec. 31, 2022 54,693          
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)         (8,223) (8,223)
Issuance of shares in connection with stock option exercise $ 2 2,648       $ 2,650
Issuance of shares in connection with stock option exercise (in shares) 1,674         1,673,000
Issuance of shares in connection with restricted stock units vesting $ 1         $ 1
Issuance of shares in connection with restricted stock units vesting (in shares) 1,078          
Issuance of shares in connection with BOD Fees   23       23
Issuance of shares in connection with BOD Fees (in shares) 5          
Issuance of shares in connection with ESPP   483       $ 483
Issuance of shares in connection with ESPP (in shares) 114         114,000
Share-based compensation   12,479       $ 12,479
Stock repurchase   (24) (4,287)     (4,311)
Actuarial gain (loss) on defined benefit plan       (305)   (305)
Unrealized gain (loss) on deferred compensation trust assets       (38)   (38)
Ending balance at Dec. 30, 2023 $ 60 $ 312,874 $ (11,912) $ 783 $ (188,974) $ 112,831
Ending balance (in shares) at Dec. 30, 2023 57,564